Growth Metrics

LifeMD (LFMD) Cost of Revenue (2016 - 2025)

LifeMD filings provide 14 years of Cost of Revenue readings, the most recent being -$12.4 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 282.43% to -$12.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.3 million, a 64.43% decrease, with the full-year FY2025 number at $11.1 million, down 48.35% from a year prior.
  • Cost of Revenue hit -$12.4 million in Q4 2025 for LifeMD, down from $3.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $29.1 million in Q2 2025 to a low of -$54.2 million in Q4 2022.
  • Median Cost of Revenue over the past 5 years was $2.8 million (2025), compared with a mean of $1.9 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 14873.56% in 2021 and later crashed 282.43% in 2025.
  • LifeMD's Cost of Revenue stood at -$43.4 million in 2021, then fell by 24.97% to -$54.2 million in 2022, then soared by 126.3% to $14.3 million in 2023, then tumbled by 52.3% to $6.8 million in 2024, then crashed by 282.43% to -$12.4 million in 2025.
  • The last three reported values for Cost of Revenue were -$12.4 million (Q4 2025), $3.0 million (Q3 2025), and $29.1 million (Q2 2025) per Business Quant data.